
Relive the original Bio Inc. experience, rebuilt from the ground up for PC to celebrate its 15th anniversary. Develop deadly diseases, cripple your victim’s body, and determine their ultimate fate in this biomedical strategy simulator.
Revenue comes from in-game items and microtransactions, which our price-based model doesn't estimate. The player count below is how many people own it, not what they spent.
Trends
Steam followers (game-group members) tracked daily from when we started recording.
Showing the last 90 days (the review-based charts: the last 4 monthly points). Full history and CSV export come with a free account.
Momentum
Pace estimated from the game's recent review growth (our daily snapshots) at its own sales-per-review ratio — a momentum signal, not booked sales.
Related
Related
Related
| Game | Estimated lifetime revenue | Reviews | Review score | Price |
|---|---|---|---|---|
| approximately $0 | 0 | — | Free | |
| approximately $0 | 0 | — | Free | |
| approximately $0 | 0 | — | Free | |
| approximately $28.3M | 65.9K | 94% | $14.99 | |
| approximately $456.3K | 3.5K | 88% | $6.99 | |
| approximately $284.7K | 582 | 90% | $17.99 |